Structural abnormalities in the brains of human subjects who use methamphetamine

Journal of Neuroscience

Volumn 24, Issue 26, 2004, Pages 6028-6036

  Thompson, Paul M ^a   Hayashi, Kiralee M ^a   Simon, Sara L ^a   Geaga, Jennifer A ^a   Hong, Michael S ^a   Sui, Yihong ^a   Lee, Jessica Y ^a   Toga, Arthur W ^a   Ling, Walter ^a   London, Edythe D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brain imaging; Cortex; Drug abuse; Hippocampus; Limbic system; Memory; Methamphetamine; MRI

Indexed keywords

METHAMPHETAMINE;

ADAPTATION; ADULT; ARTICLE; BRAIN CORTEX; BRAIN INJURY; BRAIN MAPPING; BRAIN METABOLISM; BRAIN SIZE; BRAIN VENTRICLE; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG ABUSE; FEMALE; GLIA; GLIOSIS; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; HYPERTROPHY; IMAGE ANALYSIS; LIMBIC CORTEX; LIMBIC SYSTEM; MALE; MEDIAL TEMPORAL LOBE; MEMORY; MEMORY DISORDER; MYELINATION; NERVE CELL LESION; NERVE CELL NECROSIS; NEUROADAPTATION; NEUROIMAGING; NEUROPATHOLOGY; NEUROPIL; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; TEMPORAL LOBE; WHITE MATTER; WHITE MATTER HYPERTROPHY;

ADULT; AMPHETAMINE-RELATED DISORDERS; BRAIN; BRAIN MAPPING; CEREBRAL CORTEX; DOMINANCE, CEREBRAL; FEMALE; GYRUS CINGULI; HIPPOCAMPUS; HUMANS; HYPERTROPHY; IMAGE PROCESSING, COMPUTER-ASSISTED; LIMBIC SYSTEM; MAGNETIC RESONANCE IMAGING; MALE; MEMORY DISORDERS; METHAMPHETAMINE; MYELIN SHEATH;

EID: 3042707749     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0713-04.2004     Document Type: Article

References (65)

1. Ashburner J, Friston KJ (1999) Nonlinear spatial normalization using basis functions. Hum Brain Mapp 7:254-266.
2. Ashburner J, Friston KJ (2000) Voxel-based morphometry-the methods [review]. NeuroImage 11:805-821.
3. Bartzokis G, Beckson M, Lu PH, Nuechterlein KH, Edwards N, Mintz J (2001) Age-related changes in frontal and temporal lobe volumes in men: a magnetic resonance imaging study. Arch Gen Psychiatry 58:461-465.
4. Bartzokis G, Cummings JL, Sultzer D, Henderson VW, Nuechterlein KH, Mintz J (2003) White matter structural integrity in healthy aging adults and patients with Alzheimer disease: a magnetic resonance imaging study. Arch Neurol 60:393-398.
5. Beck AT, Steer RA (1987) Manual for the Revised Beck Depression Inventory. San Antonio, TX: Psychological Corp.
6. Bonson KR, Grant SJ, Contoreggi CS, Links JM, Metcalfe J, Weyl HL, Kurian V, Ernst M, London ED (2002) Neural systems and cue-induced cocaine craving. Neuropsychopharmacology 26:376-386.
7. Bookstein FL (2001) "Voxel-based morphometry" should not be used with imperfectly registered images. NeuroImage 14:1454-1462.
8. Brody AL, Mandelkern M, London ED, Childress AR, Lee GS, Bota RG, Ho ML, Saxena S, Baxter LR, Madsen D, Jarvik ME (2002) Brain metabolic changes during cigarette craving. Arch Gen Psychiatry 59:1162-1172.
9. Brody AL, Mandelkern MA, Jarvik ME, Lee GS, Smith EC, Huang JC, Bota RG, Bartzokis G, London ED (2004) Differences between smokers and non-smokers in regional gray matter volumes and densities. Biol Psychiatry 55:77-84.
10. Bullmore ET, Suckling J, Overmeyer S, Rabe-Hesketh S, Taylor E, Brammer MJ (1999) Global, voxel, and cluster tests, by theory and permutation, for a difference between two groups of structural MR images of the brain. IEEE Trans Med Imaging 18:32-42.
11. Cabeza R, Nyberg L (2000) Imaging cognition II: an empirical review of 275 PET and fMRI studies [review]. J Cogn Neurosci 12:1-47.
12. Chang L, Ernst T, Speck O, Patel H, DeSilva M, Leonido-Yee M, Miller EN (2002) Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users. Psychiatry Res 114:65-79.
13. Childress AR, Mozley PD, McElgin W, Fitzgerald J, Reivich M, O'Brien CP (1999) Limbic activation during cue-induced cocaine craving. Am J Psychiatry 156:11-18.
14. Commins DL, Seiden LS (1986) Alpha-methyltyrosine blocks methylamphetamine-induced degeneration in the rat somatosensory cortex. Brain Res 365:15-20.
15. Denckla MB (1985) Revised neurological examination for subtle signs. Psychopharmacol Bull 21:773-800.
16. Donovan SL, Mamounas LA, Andrews AM, Blue ME, McCasland JS (2002) GAP-43 is critical for normal development of the serotonergic innervation in forebrain. J Neurosci 22:3543-3552.
17. Drevets WC (2000) Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression [review]. Prog Brain Res 126:413-431.
18. Ernst T, Chang L, Leonido-Yee M, Speck O (2000) Evidence for long-term neurotoxicity associated with methamphetamine abuse: a 1H MRS study. Neurology 54:1344-1349.
19. Escubedo E, Guitart L, Sureda FX, Jimenez A, Pubill D, Pallas M, Camins A, Camarasa J (1998) Microgliosis and down-regulation of adenosine transporter induced by methamphetamine in rats. Brain Res 814:120-126.
20. First MB, Spitzer RL, Gibbon M, Williams J (1996) Structured Clinical Interview for DSM-IV Axis I disorders. Patient Edition (SCID-IP, version 2.0). New York: Biometrics Research Department, New York State Psychiatric Institute.
21. Garavan H, Pankiewicz J, Bloom A, Cho JK, Sperry L, Ross TJ, Salmeron BJ, Risinger R, Kelley D, Stein EA (2000) Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli. Am J Psychiatry 157:1789-1798.
22. Goldstein RZ, Volkow ND (2002) Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex [review]. Am J Psychiatry 159:1642-1652.
23. Good CD, Johnsrude I, Ashburner J, Henson RN, Friston KJ, Frackowiak RS (2001) Cerebral asymmetry and the effects of sex and handedness on brain structure: a voxel-based morphometric analysis of 465 normal adult human brains. Neurolmage 14:685-700.
24. Iyo M, Namba H, Yanagisawa M, Hirai S, Yui N, Fukui S (1997) Abnormal cerebral perfusion in chronic methamphetamine abusers: a study using 99MTc-HMPAO and SPECT. Prog Neuropsychopharmacol Biol Psychiatry 21:789-796.
25. Jernigan TL, Archibald SL, Gamst AC, Fennema-Notestine C, Grant I, Ellis RO (2003) Effects of HIV, age, and methamphetamine abuse on brain structure. Soc Neurosci Abstr 29:135.1.
26. Kalechstein AD, Newton TF, Green M (2003) Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence. J Neuropsychiatry Clin Neurosci 15:215-220.
27. Kao CH, Wang SJ, Yeh SH (1994) Presentation of regional cerebral blood flow in amphetamine abusers by 99Tcm-HMPAO brain SPECT. Nucl Med Commun 15:94-98.
28. Kilts CD, Schweitzer JB, Quinn CK, Gross RE, Faber TL, Muhammad F, Ely TD, Hoffman JM, Drexler KP (2001) Neural activity related to drug craving in cocaine addiction. Arch Gen Psychiatry 58:334-341.
29. Kokoshka JM, Vaughan RA, Hanson GR, Fleckenstein AE (1998) Nature of methamphetamine-induced rapid and reversible changes in dopamine transporters. Eur J Pharmacol 361:269-275.
30. Larsen KE, Fon EA, Hastings TG, Edwards RH, Sulzer D (2002) Methamphetamine-induced degeneration of dopaminergic neurons involves autophagy and upregulation of dopamine synthesis. J Neurosci 22:8951-8960.
31. Lawrie SM, Abukmeil SS (1998) (1998) Brain abnormality in schizophrenia. Asystematic and quantitative review of volumetric magnetic resonance imaging studies [review]. Br J Psychiatry 172:110-120.
32. London ED, Simon SL, Berman SM, Mandelkern MA, Lichtman AM, Bramen J, Shinn AK, Miotto K, Learn J, Dong Y, Matochik JA, Kurian V, Newton T, Woods RP, Rawson R, Ling W (2004) Regional cerebral dysfunction associated with mood disturbances in abstinent methamphetamine abusers. Arch Gen Psychiatry 61:73-84.
33. Maas LC, Lukas SE, Kaufman MJ, Weiss RD, Daniels SL, Rogers VW, Kukes TJ, Renshaw PF (1998) Functional magnetic resonance imaging of human brain activation during cue-induced cocaine craving. Am J Psychiatry 155:124-126.
34. MacDonald D, Kabani N, Avis D, Evans AC (2000) Automated 3-D extraction of inner and outer surfaces of cerebral cortex from MRI. NeuroImage 12:340-356.
35. 11C]WIN-35,428. J Neurosci 18:8417-8422.
36. McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H (1992) The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat 9:199-213.
37. Narr KL, van Erp TG, Cannon TD, Woods RP, Thompson PM, Jang S, Blanton R, Poutanen VP, Huttunen M, Lonnqvist J, Standerksjold-Nordenstam CG, Kaprio J, Mazziotta JC, Toga AW (2002) A twin study of genetic contributions to hippocampal morphology in schizophrenia. Neurobiol Dis 11:83-95.
38. Ono M, Kubik S, Abernathey CD (1990) Atlas of the cerebral sulci. Stuttgart, Germany: Thieme.
39. Paulus MP, Hozack NE, Zauscher BE, Frank L, Brown GG, Braff DL, Schuckit MA (2002) Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphetamine-dependent subjects. Neuropsychopharmacology 26:53-63.
40. Perez JA, Arsura EL, Strategos S (1999) Methamphetamine-related stroke: four cases. J Emerg Med 17:469-471.
41. Pubill D, Canudas AM, Pallas M, Camins A, Camarasa J, Escubedo E (2003) Different glial response to methamphetamine- and methylenedioxy-methamphetamine- induced neurotoxicity. Naunyn Schmiedebergs Arch Pharmacol 367:490-499.
42. Reitan RM (1958) Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 8:271-276.
43. Ricaurte GA, Schuster CR, Seiden LS (1980) Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study. Brain Res 193:153-163.
44. Salmond CH, Ashburner J, Vargha-Khadem F, Connelly A, Gadian DG, Friston KJ (2002) The precision of anatomical normalization in the medial temporal lobe using spatial basis functions. Neurolmage 17:507-512.
45. Salo R, Nordahl TE, Possin K, Leamon M, Gibson DR, Galloway GP, Flynn NM, Henik A, Pfefferbaum A, Sullivan EV (2002) Preliminary evidence of reduced cognitive inhibition in methamphetamine-dependent individuals. Psychiatry Res 111:65-74.
46. Sekine Y, Iyo M, Ouchi Y, Matsunaga T, Tsukada H, Yoshikawa E, Futatsubashi M, Takei N, Mori N (2001) Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. Am J Psychiatry 158:1206-1214.
47. Sekine Y, Minabe Y, Ouchi Y, Takei N, Iyo M, Nakamura K, Suzuki K, Tsukada H, Yoshikawa E, Futatsubashi M, Mori N (2003) Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortex with methamphetamine-related psychiatric symptoms. Am J Psychiatry 160:1699-1701.
48. Simon SL (1999) Repeated memory test. In: Treatment for stimulant use disorders, pp 207-218. Rockville, MD: United States Department of Health and Human Services.
49. Simon SL, Domier C, Carnell J, Brethen P, Rawson R, Ling W (2000) Cognitive impairment in individuals currently using methamphetamine. Am J Addict 9:222-231.
50. Simon SL, Domier CP, Sim T, Richardson K, Rawson RA, Ling W (2002) Cognitive performance of current methamphetamine and cocaine abusers. J Addict Dis 21:61-74.
51. Snodgrass JG, Vanderwart M (1980) A standardized set of 260 pictures: norms for name agreement, image agreement, familiarity, and visual complexity. J Exp Psychol [Hum Learn] 6:174-215.
52. Sowell ER, Thompson PM, Tessner KD, Toga AW (2001) Mapping continued brain growth and gray matter density reduction in dorsal frontal cortex: inverse relationships during postadolescent brain maturation. J Neurosci 21:8819-8829.
53. Sowell ER, Peterson BS, Thompson PM, Welcome SE, Henkenius AL, Toga AW (2003) Mapping cortical change across the human lifespan. Nat Neurosci 6:309-315.
54. Spielberger CD (1983) Manual for the State-Trait Anxiety Inventory (Form Y). Palo Alto, CA: Consulting Psychologists.
55. Takahashi T, Suzuki M, Kawasaki Y, Kurokawa K, Hagino H, Yamashita I, Zhou SY, Nohara S, Nakamura K, Seto H, Kurachi M (2002) Volumetric magnetic resonance imaging study of the anterior cingulate gyrus in schizotypal disorder. Eur Arch Psychiatry Clin Neurosci 252:268-277.
56. Thompson PM, Toga AW (2002) A framework for computational anatomy. Comput Vis Sci 5:1-12.
57. Thompson PM, Hayashi KM, de Zubicaray G, Janke AL, Rose SE, Semple J, Herman D, Hong MS, Dittmer S, Doddrell DM, Toga AW (2003) Dynamics of gray matter loss in Alzheimer's disease. J Neurosci 23:994-1005.
58. United Nations Office on Drugs and Crime (2003) Ecstasy and amphetamines, Global Survey 2003. New York. United Nations.
59. Vogt BA, Berger GR, Derbyshire SW (2003) Structural and functional dichotomy of human midcingulate cortex. Eur J Neurosci 18:3134-3144.
60. Volkow ND, Chang L, Wang GJ, Fowler JS, Leonido-Yee M, Franceschi D, Sedler MJ, Gatley SJ, Hitzemann R, Ding YS, Logan J, Wong C, Miller EN (2001) Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 158:377-382.
61. Watkins KE, Paus T, Lerch JP, Zijdenbos A, Collins DL, Neelin P, Taylor J, Worsley KJ, Evans AC (2001) Structural asymmetries in the human brain: a voxel-based statistical analysis of 142 MRI scans. Cereb Cortex 11:868-877.
62. Wechsler D (1981) Manual for the Wechsler Adult Intelligence Scale, revised. New York: The Psychological Corporation.
63. Wexler BE, Gottschalk GH, Fulbright RK, Prohovnik I, Lacadie CM, Rounsaville BJ, Gore JC (2001) Functional magnetic resonance imaging of cocaine craving. Am J Psychiatry 158:86-95.
64. Wright IC, McGuire PK, Poline JB, Travere JM, Murray RM, Frith CD, Frackowiak RS, Friston KJ (1995) A voxel-based method for the statistical analysis of gray and white matter density applied to schizophrenia. NeuroImage 2:244-252.
65. Yen DJ, Wang SJ, Chen CC, Liao KK, Fuh JL, Hu HH (1994) Stroke associated with methamphetamine inhalation. Eur Neurol 34:16-22.